Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
0
IAVI-W001 Study Launched at the KAVI-Institute of Clinical Research
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
0
KAVI-ICR shines at the SANTHE annual consortium meeting
KAVI-Institute of Clinical Research (KAVI-ICR) was privileged to have been represented at the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) annual consortium meeting (ACM) held in Kigali, Rwanda, at the Marriott Hotel from the 3rd to the 7th of November, 2025. SANTHE aims to shape and drive locally relevant basic, clinical and translational research in Africa, with all of the research conducted under SANTHE being led by African scientists.